Waters’ New Bioseparation Tools Enhance and Accelerate RNA-based Vaccine and Therapy Development with LC-MS Analysis
Waters Corporation today unveiled a new suite of sample preparation enzymes, reagents, and the waters_connect software, designed to simplify the sequence and modification confirmation of large-molecule RNA therapeutics using liquid…